Public Health

Lyme Disease

Lyme disease is a tick-borne illness that affects people all over the world. Current conventional surveillance methods involve passive and active detection, both of which require multiple steps. This process uses inefficient methods which require samples to be sent to the lab for identification. Not only is this a time-consuming process, but it also requires additional human resources which increases the costs associated with surveillance.

With eDNA, the entire process of shipping samples to various labs is eliminated. This not only saves time but also cuts costs. Using our TripleLockTM platform, the timeline for the process is reduced to just 80 minutes. This means that surveillance maps can be updated in real-time which allows for the public to be better informed about which areas to avoid. Moreover, the assays developed for the molecular tests are thoroughly validated to ensure high specificity and sensitivity for accurate detection.”

West Nile Virus Surveillance section

West Nile Virus is a vector-borne disease that is of public health importance in Ontario. Effective prevention of human WNV infections depends on the development of comprehensive mosquito surveillance and control programs (World Health Organization, 2017). Current methods used for WNV surveillance are labour intensive as it requires shipping samples to labs for taxonomic identification. This also makes the process more time consuming and costly. Using environmental DNA (eDNA) and PBIs TripleLockTM platform allows for the entire surveillance protocol to be improved. The process would only involve sample collection, preparation, and on-site analysis. Results would also be available within 80 minutes. The key benefit of the fast turn-around time being that surveillance maps can be updated in real-time. The infographic below depicts the benefits of eDNA biomonitoring compared to the conventional method for WNV surveillance.

African Swine Fever Virus

Introducing the world’s only rapid, onsite test to detect the presence of African Swine Fever Virus (ASFV). Our rapid, onsite diagnostic test provides reliable results enables a more immediate response to curtailing the further spread of the virus. This will contribute to reducing the losses associated with the disease. Further, a rapid, in-situ test that can be performed and verified in about an hour would enable more effective and pervasive surveillance to prevent infection of domestic swine.

The test procedure will detect the presence of the virus in any infected animal or carrier of the virus. Unlike laboratory services that require samples to be shipped where they may be prepared for DNA extraction and detection, then our solution is mobile and can be employed at any time, anywhere by anyone.